168 related articles for article (PubMed ID: 12121133)
1. Polyethylene glycol conjugates of methotrexate varying in their molecular weight from MW 750 to MW 40000: synthesis, characterization, and structure-activity relationships in vitro and in vivo.
Riebeseel K; Biedermann E; Löser R; Breiter N; Hanselmann R; Mülhaupt R; Unger C; Kratz F
Bioconjug Chem; 2002; 13(4):773-85. PubMed ID: 12121133
[TBL] [Abstract][Full Text] [Related]
2. Antitumor properties and toxicity of dextran-methotrexate conjugates are dependent on the molecular weight of the carrier.
Nevozhay D; Budzynska R; Kanska U; Jagiello M; Omar MS; Boratynski J; Opolski A
Anticancer Res; 2006; 26(2A):1135-43. PubMed ID: 16619515
[TBL] [Abstract][Full Text] [Related]
3. Growth inhibition, drug load, and degradation studies of gelatin/methotrexate conjugates.
Ofner CM; Pica K; Bowman BJ; Chen CS
Int J Pharm; 2006 Feb; 308(1-2):90-9. PubMed ID: 16361072
[TBL] [Abstract][Full Text] [Related]
4. Lipophilic methotrexate conjugates with antitumor activity.
Pignatello R; Spampinato G; Sorrenti V; Di Giacomo C; Vicari L; McGuire JJ; Russell CA; Puglisi G; Toth I
Eur J Pharm Sci; 2000 May; 10(3):237-45. PubMed ID: 10767601
[TBL] [Abstract][Full Text] [Related]
5. PEG-doxorubicin conjugates: influence of polymer structure on drug release, in vitro cytotoxicity, biodistribution, and antitumor activity.
Veronese FM; Schiavon O; Pasut G; Mendichi R; Andersson L; Tsirk A; Ford J; Wu G; Kneller S; Davies J; Duncan R
Bioconjug Chem; 2005; 16(4):775-84. PubMed ID: 16029018
[TBL] [Abstract][Full Text] [Related]
6. Characterization and in vitro methotrexate release from methotrexate/gelatin conjugates of opposite conjugate bond polarity.
Bowman BJ; Ofner CM
Pharm Res; 2000 Oct; 17(10):1309-15. PubMed ID: 11145239
[TBL] [Abstract][Full Text] [Related]
7. Activity of dendrimer-methotrexate conjugates on methotrexate-sensitive and -resistant cell lines.
Gurdag S; Khandare J; Stapels S; Matherly LH; Kannan RM
Bioconjug Chem; 2006; 17(2):275-83. PubMed ID: 16536456
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate esters of poly(ethylene oxide)-block-poly(2-hydroxyethyl-L-aspartamide). Part I: Effects of the level of methotrexate conjugation on the stability of micelles and on drug release.
Li Y; Kwon GS
Pharm Res; 2000 May; 17(5):607-11. PubMed ID: 10888314
[TBL] [Abstract][Full Text] [Related]
9. Characterization and in vitro release of methotrexate from gelatin/methotrexate conjugates formed using different preparation variables.
Kosasih A; Bowman BJ; Wigent RJ; Ofner CM
Int J Pharm; 2000 Aug; 204(1-2):81-9. PubMed ID: 11011989
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of site-specific methotrexate-IgG conjugates. Comparison of stability and antitumor activity with active-ester-based conjugates.
Kralovec J; Singh M; Mammen M; Blair AH; Ghose T
Cancer Immunol Immunother; 1989; 29(4):293-302. PubMed ID: 2787696
[TBL] [Abstract][Full Text] [Related]
11. [Liposomal formulation of a methotrexate diglyceride conjugate: activity in methotrexate-resistant leukemia cultured cells].
Vodovozova EL; Kuznetsova NR; Gaenko GP; Molotkovskiĭ IuG
Bioorg Khim; 2007; 33(4):470-3. PubMed ID: 17886439
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo antitumor activity of methotrexate conjugated to human serum albumin in human cancer cells.
Wosikowski K; Biedermann E; Rattel B; Breiter N; Jank P; Löser R; Jansen G; Peters GJ
Clin Cancer Res; 2003 May; 9(5):1917-26. PubMed ID: 12738750
[TBL] [Abstract][Full Text] [Related]
13. Pre-clinical evaluation of a methotrexate-albumin conjugate (MTX-HSA) in human tumor xenografts in vivo.
Burger AM; Hartung G; Stehle G; Sinn H; Fiebig HH
Int J Cancer; 2001 Jun; 92(5):718-24. PubMed ID: 11340578
[TBL] [Abstract][Full Text] [Related]
14. Hydrolysis of methotrexate-immunoglobulin conjugates by liver homogenates and characterization of catabolites.
Uadia PO; Blair AH; Ghose T
Cancer Chemother Pharmacol; 1988; 22(2):175-7. PubMed ID: 3409449
[TBL] [Abstract][Full Text] [Related]
15. Dihydrofolate reductase binding and cellular uptake of nonpolyglutamatable antifolates: correlates of cytotoxicity toward methotrexate-sensitive and -resistant human head and neck squamous carcinoma cells.
Chen G; Wright JE; Rosowsky A
Mol Pharmacol; 1995 Oct; 48(4):758-65. PubMed ID: 7476904
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate-immobilized poly(ethylene glycol) magnetic nanoparticles for MR imaging and drug delivery.
Kohler N; Sun C; Fichtenholtz A; Gunn J; Fang C; Zhang M
Small; 2006 Jun; 2(6):785-92. PubMed ID: 17193123
[TBL] [Abstract][Full Text] [Related]
17. The effect of molecular weight, drug load, and charge of gelatin-MTX conjugates on growth inhibition of HL-60 leukemia cells.
Chen CS; Ofner CM
Pharm Res; 2009 Feb; 26(2):338-45. PubMed ID: 18975058
[TBL] [Abstract][Full Text] [Related]
18. The use of protein as a carrier of methotrexate for experimental cancer chemotherapy. III. Human serum albumin-methotrexate derivative, its preparation and basic testing.
Bures L; Bostík J; Motycka K; Spundová M; Rehák L
Neoplasma; 1988; 35(3):329-42. PubMed ID: 3405341
[TBL] [Abstract][Full Text] [Related]
19. Acid-sensitive polyethylene glycol conjugates of doxorubicin: preparation, in vitro efficacy and intracellular distribution.
Rodrigues PC; Beyer U; Schumacher P; Roth T; Fiebig HH; Unger C; Messori L; Orioli P; Paper DH; Mülhaupt R; Kratz F
Bioorg Med Chem; 1999 Nov; 7(11):2517-24. PubMed ID: 10632061
[TBL] [Abstract][Full Text] [Related]
20. The effect of the substitution level of some dextran-methotrexate conjugates on their antitumor activity in experimental cancer models.
Nevozhay D; Budzynska R; Jagiello M; Kanska U; Omar MS; Opolski A; Wietrzyk J; Boratynski J
Anticancer Res; 2006; 26(3A):2179-86. PubMed ID: 16827162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
